MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5387/fms.2018-21

Медицинская библиотека · Fukushima journal of medical science · 2018

Propofol is a more effective and safer sedative agent than midazolam in endoscopic injection sclerotherapy for esophageal varices in patients with liver cirrhosis: a randomized controlled trial.

Watanabe Ko, Hikichi Takuto, Takagi Tadayuki, Suzuki Rei, Nakamura Jun, Sugimoto Mitsuru, Kikuchi Hitomi, Konno Naoki, Takasumi Mika, Sato Yuki, Hashimoto Minami, Irie Hiroki, Obara Katsutoshi, Ohira Hiromasa

СтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVE

The efficacy of sedation during endoscopic injection sclerotherapy (EIS) for esophageal varices (EVs) in patients with liver cirrhosis remains unclear. The aim of this study is to compare the efficacy and safety between propofol- and midazolam-based sedation for EIS.

METHODS

Twenty-three patients with EVs were prospectively and randomly assigned to midazolam-based (Midazolam group) or propofol-based (Propofol group) sedation. All patients underwent a number connection test (NCT) to evaluate minimal hepatic encephalopathy (MHE) on the day before and at 2 and 24 hours following EIS. The primary endpoint was exacerbation of MHE after EIS, which was defined as deterioration of the NCT. The secondary endpoints were postoperative awareness, technical success rate, frequency of body movement, patient and operator satisfaction, cardiorespiratory dynamics during EIS, and adverse events.

RESULTS

Exacerbations of MHE at 2 hours after EIS compared with those before EIS were not significantly different between the two groups. In both groups, the deterioration of NCT scores before and 2 hours after EIS was observed (Propofol group: 60.0 vs. 70.0 s, P = 0.026; Midazolam group: 42.5 vs. 67.0 s, P = 0.002). There were no significant differences in awareness, technical success rate, or patient satisfaction. However, the frequency of body movement in the Propofol group was significantly lower than that in the Midazolam group (1 vs. 4, P = 0.045), and operator satisfaction in the Propofol group was significantly higher than that in the Midazolam group (P = 0.016). No adverse events were observed.

CONCLUSIONS

Propofol-based sedation exacerbated MHE after EIS similarly to midazolam-based sedation in patients with liver cirrhosis. However, propofol-based sedation provided stable sedation with a lower frequency of body movements and high operator satisfaction.

Для цитирования: Watanabe Ko, Hikichi Takuto, Takagi Tadayuki, Suzuki Rei, Nakamura Jun, Sugimoto Mitsuru, Kikuchi Hitomi, Konno Naoki, Takasumi Mika, Sato Yuki, Hashimoto Minami, Irie Hiroki, Obara Katsutoshi, Ohira Hiromasa. Propofol is a more effective and safer sedative agent than midazolam in endoscopic injection sclerotherapy for esophageal varices in patients with liver cirrhosis: a randomized controlled trial.. Fukushima journal of medical science. 2018. DOI: 10.5387/fms.2018-21.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.